Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001544406-12-000001
Filing Date
2012-03-14
Accepted
2012-03-14 16:47:43
Documents
1
Effectiveness Date
2012-03-14
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8498
  Complete submission text file 0001544406-12-000001.txt   9671
Mailing Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022 212-891-1100
Valence Advantage Life Sciences Fund II, L.P. (Filer) CIK: 0001544406 (see all company filings)

EIN.: 454660146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-174950 | Film No.: 12690810